BYND Cannasoft (BCAN): A Small-Cap Enterprise with Exceptional Growth Prospects in the Booming Sextech Industry

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

*Sponsored on behalf of BYND Cannasoft

As a promising small-cap enterprise operating in the sextech industry, BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) (“BYND Cannasoft” or the “Company”) has recently reached a significant milestone. The company’s subsidiary, Zigi Carmel Initiatives & Investments LTD, has filed a patent application for its AI-based EZ-G device with the World Intellectual Property Office (WIPO).

This groundbreaking device, equipped with state-of-the-art AI and machine learning technologies, as well as several sensors, promises to redefine adult toys and contribute significantly to women’s health worldwide. The patent application, listed as Publication Number WO/2023/13195, was published on WIPO’s global database for intellectual property on July 13, 2023.

A Technological Leap in the Sextech Industry

The technological sophistication of the EZ-G device truly underscores BYND Cannasoft’s unwavering commitment to innovation in the rapidly growing sextech industry. As Yftah Ben Yaackov, CEO and Director of BYND Cannasoft, has stated, “The technology behind our EZ-G device showcases our commitment to shaping the future of machine learning, as well as reflects the dedication and expertise of our talented team. We are excited about its potential impact on women’s health worldwide.”

The EZ-G device is not merely a standard adult toy. It incorporates advanced technologies to provide a more realistic and satisfying experience. It uses artificial intelligence to capture and analyze data from a variety of sensors monitoring pressure, temperature, conductivity, and heart rate. This data reflects conditions in the user’s sexual organs, such as moisture levels and muscle contractions’ pressure variations.

Moreover, the device includes a Bluetooth component that allows users to control it via a smartphone app, providing a highly personalized experience. The app collects user preferences, creating custom programs tailored to individual needs.

Utilizing Data to Maximize Pleasure

The unique feature of the EZ-G device is its ability to continuously learn and improve its operation. The data gathered from users is securely uploaded to the cloud. Factors such as the actual duration of operation, lubrication level, and ideal vibration intensity are analyzed to optimize the device’s performance, aiming to enhance sexual satisfaction. In other words, the more the device is used, the better it becomes at fulfilling the user’s needs.

A Burgeoning Market

According to Forbes, industry experts project the sextech market to reach a staggering $62.32 billion by 2030. While wearable technology has typically been associated with fitness trackers and smartwatches, an emerging trend in wearable sex toys signals a significant shift in the market. BYND Cannasoft recognizes this potential and intends to capitalize on the growth of the sextech market by innovating products designed for intelligent responses to sexual activities.

As a small-cap enterprise with an innovative product in a growing market, BYND Cannasoft holds remarkable growth potential. Its recent patent application for the EZ-G device illustrates a solid commitment to technological advancement and positions the company for future success in the sextech industry. The convergence of AI, machine learning, and adult toy technology in BYND Cannasoft’s product portfolio promises a unique and lucrative opportunity for potential investors looking for a small-cap company with significant upside.

Some on Wall Street are getting increasingly bullish on the S&P 500, raising their price targets for the index. Oppenheimer Asset Management was the latest to do so. It increased its year-end S&P 500 price target from 4,400 to 4,900 — the highest in CNBC’s Market Strategist survey. That follows Citi raising its S&P 500 target to 4,600 last week from 4,000. Citi also hiked its mid-2024 target to 5,000 from 4,400.

The stock market closed on a positive note with several companies recording substantial gains. EQRx, Inc. (EQRX) shares increased by 7.43%, closing at $2.17. The company has a market capitalization of approximately $1.06 billion, a trading volume of 3.65 million, and a total number of shares outstanding at 63.26 million. Rubicon Technologies, Inc. (RBT) witnessed a significant surge of 41.80% in their shares, closing at $1.73, with a market cap of $331.16 million, and a total of 29.78 million shares. Rite Aid Corporation (RAD) saw an encouraging increase of 31.76%, ending the day at $2.24 per share, with a market cap of $127.00 million and approximately 56.76 million shares outstanding. Advanced Health Intelligence Ltd. (AHI) also experienced an impressive hike of 33.98%, closing at $4.14, and a market cap of $115.95 million, with around 32.12 million shares. AEye, Inc. (LIDR) had a 15.13% increase, closing at $0.6451, with a market cap of $114.11 million, and total shares standing at 67.79 million.

Source: https://finance.yahoo.com/news/israeli-technology-company-bynd-cannasoft-123000959.html

Disclaimer: *Sponsored on behalf of BYND Cannasoft. Please ensure to fully read and comprehend our disclaimer found at https://investorbrandmedia.com/disclaimer/. We have been compensated one thousand and five hundred dollars by a 3rd party on behalf of BYND Cannasoft for ticker tagging advertisement services on BCAN from 31st July, 2023 to 4th August, 2023. InvestorBrandMedia.com is neither an investment advisor nor a registered broker. No current owner, employee, or independent contractor of InvestorBrandMedia.com is registered as a securities broker-dealer, broker, investment advisor, or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. This article may contain forward-looking statements as defined under Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. These statements, often incorporating terms like “believes,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” or similar expressions about future performance or conduct, are based on present expectations, estimates, and projections, and are not historical facts. They carry various risks and uncertainties that may result in significant deviation from the anticipated results or events. Past performance does not guarantee future results.InvestorBrandMedia.com does not commit to updating forward-looking statements based on new information or future events. Readers are encouraged to review all public SEC filings made by the profiled companies at https://www.sec.gov/edgar/searchedgar/companysearch. It is always important to conduct thorough due diligence and exercise caution in trading.InvestorBrandMedia.com is not managed by a licensed broker, a dealer, or a registered investment adviser. The content here is purely informational and should not be taken as investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor regarding forward-looking statements. Any statement that projects, foresees, expects, anticipates, estimates, believes, or understands certain actions to possibly occur are not historical facts and may be forward-looking statements. These statements are based on expectations, estimates, and projections that could cause actual results to differ greatly from those anticipated. Investing in micro-cap and growth securities is speculative and entails a high degree of risk, potentially leading to a total or substantial loss of investment. Please note that no content published here constitutes a recommendation to buy or sell a security. It is solely informational, and you should not construe it as legal, tax, investment, financial, or other advice. No content in this article constitutes an offer or solicitation by InvestorBrandMedia.com or any third-party service provider to buy or sell securities or other financial instruments. The content in this article does not address the circumstances of any specific individual or entity and does not constitute professional and/or financial advice. InvestorBrandMedia.com is not a fiduciary by virtue of any person’s use of or access to this content. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE.